CTS Corporation Stock Is A Sleeper Play For The Budding Rebound

CTS Corporation Stock Is A Sleeper Play For The Budding ReboundCTS Corporation Is Fundamental To The Recovery

CTS Corporation (NYSE:CTS) is among a quietly thriving group of companies that are perfectly positioned for the recovery. CTS Corporation, like PPG Industries (NYSE:PPG), H.B. Fuller (NYSE:FUL), and Avient (NYSE:AVNT), manufactures and markets supplies that are not only fundamental to the manufacturing industry at large but also very, very necessary for several accelerating global trends.

In the case of CTS Corporation, this means electrical components, sensors, and actuators. The company’s clients rank among the world’s leading OEM manufacturers and tier-one suppliers servicing the automotive, aerospace/defense, information technology, medical, industrial, and transportation industries. Industries supported by trends like 5G, EV, the cloud, healthcare, and consumer technology.

CTS Falls After Cautious Guidance

CTS Corporation issued a very solid Q4 report and a positive, if cautious, outlook for the 2021 fiscal period. The company pulled in $123 million in net consolidated revenue for the quarter which is up to both sequentially and from last year. The revenue is up nearly 9.0% from last quarter and 7% from last year as business accelerates to its pre-pandemic levels. The revenue strength was driven by a 12% gain in the transportation segment that was offset in flat to slightly higher revenue in all other segments.


Moving down to the margins, the revenue gains were accentuated by a margin improvement worth 110 basis points for both adjusted gross and operating margins. Adjusted margin rose to 21.4% from last year’s 20.3% to drive solid gains on the bottom line. On the bottom line the GAAP EPS of $0.46 grew 50% from last year and beat the consensus by $0.11. On an adjusted basis, EPS grew 16% from last year and beat by $0.09.

The company says it is still on track to meet or exceed its 2025 targets despite the pandemic. The company is targeting 10% annualized revenue growth and is planning on meeting that goal through organic and acquisitional gains. The guidance for 2021 is good albeit the margin for error is quite wide. The company is expecting revenue in the range of $430 to $490 million with EPS running $1.20 to $1.60. That compares with the consensus of $450 in revenue and $1.45 earnings and does not factor in what we think could be a very strong economic rebound in the second half of the year.

A Value And A Safe Dividend, With A Catch

CTS Corporation offers a bit of a value compared to the broader market trading at 20X its 2021 EPS consensus estimate. Assuming that the company’s guidance is cautious and that revisions will narrow the range toward the high-end the value is even deeper and there is also the dividend to consider. The company is not known as a dividend-grower but has paid a very stable and reliable distribution for over a decade with some increases in its history. The balance sheet is in great shape, the payout ratio is a mere 10%, and business is accelerating so there is no reason to fear a cut or suspension. The catch is the yield. AT only 0.50% it doesn’t offer much other than stability.

The Technical Outlook: A Make Or Break Moment For CTS Corporation

The shares of CTS Corporation initially moved higher after the Q4 release but the market couldn’t hold the gains. By the end of the session, the stock was down 2.0% and showing resistance at the short-term moving average. The indicators are still mixed but are consistent with a shift in momentum that could take the stock higher if resistance at the EMA can be broken. If that were to happen investors might expect to price action move up to the $36 level. If not then a retest of the $30 level is the more likely scenario. Longer-term, however, we see this stock moving higher as the economic recovery gains momentum.

CTS Corporation (NYSE:CTS) Is A Sleeper Play For The Budding Rebound

Should you invest $1,000 in CTS right now?

Before you consider CTS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CTS wasn't on the list.

While CTS currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
CTS (CTS)
3.45 of 5 stars
$45.64+0.3%0.35%23.77Hold$43.67
PPG Industries (PPG)
4.6236 of 5 stars
$130.52+0.1%1.99%22.05Moderate Buy$155.50
H.B. Fuller (FUL)
4.1955 of 5 stars
$75.03-1.4%1.09%27.28Hold$86.20
Avient (AVNT)
4.4226 of 5 stars
$43.25-0.1%2.38%52.11Moderate Buy$44.00
Compare These Stocks  Add These Stocks to My Watchlist 

Thomas Hughes

About Thomas Hughes

  • tmhughes.writeon@gmail.com

Contributing Author

Technical and Fundamental Analysis

Experience

Thomas Hughes has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies

Education

Associate of Arts in Culinary Technology

Past Experience

Market watcher, trader and investor for numerous websites. Founded Passive Market Intelligence LLC to provide market research insights. 


Featured Articles and Offers

Search Headlines: